NCT03396341 - Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

January 4, 2018

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Genetic TestingBRCA1/2

Interventions

OTHER

Salvia sample

salvia sample

BEHAVIORAL

Questionnaires

Participants will complete Assessment #1 questionnaires. Participants will be contacted 1 week later (+/- 1 week) to complete Assessment #2 questionnaires. Participants will be contacted 6 months (+/- 3 weeks) following the receipt of their genetic risk modifier results to complete Assessment #3 questionnaires. Participants will be encouraged to complete Assessments #2 and #3 via email using the secure, approved REDCap system

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester, Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau, Uniondale

11725

RECRUITING

Memorial Sloan Kettering Commack, Commack

02115

RECRUITING

Dana Farber Cancer Institute (Data Collection Only), Boston

07920

RECRUITING

Memorial Sloan-Kettering at Basking Ridge, Basking Ridge

19104-4283

RECRUITING

Abramson Cancer Center at University of Pennsylvania Medical Center (Data Collection Only), Philadelphia